未来发展控股(01259.HK)预计中期税后净亏损扩大至5800元-7300元
格隆汇8月13日丨未来发展控股(01259.HK)公布,公司管理层估计,公司截至2019年6月30日止6个月录得营运亏损。公司估计,截至2019年6月30日止6个月,集团的税后净亏损约人民币5800元-7300元,而上年同期则录得税后净亏损约人民币4790万元。
有关额外亏损主要由于(1)个人护理产品的收益因中华人民共和国经济放缓而减少;及(2)买卖商品业务的持续亏损所致。
此外,集团按公平值透过其他全面收益列账的金融资产录得已变现亏损及未变现亏损分别约人民币440万元及人民币3890万元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.